{"id":136510,"date":"2025-06-19T11:28:11","date_gmt":"2025-06-19T10:28:11","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/"},"modified":"2025-06-19T11:28:11","modified_gmt":"2025-06-19T10:28:11","slug":"ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/","title":{"rendered":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH"},"content":{"rendered":"<p>La Administraci\u00f3n de Alimentos y Medicamentos (FDA) de Estados Unidos aprob\u00f3 este mi\u00e9rcoles el primer tratamiento semestral preventivo del VIH de venta en el pa\u00eds, seg\u00fan anunci\u00f3 el fabricante del medicamento, Gilead Sciences.<\/p>\n<p>El f\u00e1rmaco, llamado Yeztugo (lenacapavir), fue dise\u00f1ado para reducir el riesgo de contraer VIH por v\u00eda sexual en adultos y adolescentes que pesen al menos 35 kilogramos. El inhibidor inyectable es la primera y \u00fanica opci\u00f3n semestral disponible en EE UU para personas que necesitan o desean recibir el tratamiento.<\/p>\n<p>Los ensayos cl\u00ednicos demostraron que el 99,9 % de los participantes que lo recibieron permanecieron VIH negativos<\/p>\n<p>Daniel O&#8217;Day, presidente y director ejecutivo de Gilead, calific\u00f3 la aprobaci\u00f3n como un \u201cmomento clave en la lucha de d\u00e9cadas contra el VIH\u201d, seg\u00fan dijo en un comunicado. Los ensayos cl\u00ednicos demostraron que el\u00a099,9 %\u00a0de los participantes que lo recibieron permanecieron VIH negativos.<\/p>\n<p>\u201cYeztugo nos ayudar\u00e1 a prevenir el VIH a una escala nunca antes vista. Ahora tenemos una manera de acabar con la epidemia del VIH de una vez por todas\u201d, agreg\u00f3 O&#8217;Day.<\/p>\n<p><a><\/a><\/p>\n<h2>Superar la adherencia y el estigma<\/h2>\n<p>Port su parte, el m\u00e9dico Carlos del R\u00edo, codirector del Centro Emory para la Investigaci\u00f3n del SIDA en Atlanta (Georgia), afirm\u00f3 que la inyecci\u00f3n semestral podr\u00eda superar \u201cen gran medida\u201d barreras clave, como la adherencia y el estigma, que pueden enfrentar las personas con reg\u00edmenes de dosificaci\u00f3n m\u00e1s frecuentes, especialmente la medicina oral diaria.<\/p>","protected":false},"excerpt":{"rendered":"<p>La Administraci\u00f3n de Alimentos y Medicamentos (FDA) de Estados Unidos aprob\u00f3 este mi\u00e9rcoles el primer tratamiento semestral preventivo del VIH de venta en el pa\u00eds, seg\u00fan anunci\u00f3 el fabricante del medicamento, Gilead Sciences. El f\u00e1rmaco, llamado Yeztugo (lenacapavir), fue dise\u00f1ado para reducir el riesgo de contraer VIH por v\u00eda sexual en adultos y adolescentes que [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[5],"tags":[],"class_list":["post-136510","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH\" \/>\n<meta property=\"og:description\" content=\"La Administraci\u00f3n de Alimentos y Medicamentos (FDA) de Estados Unidos aprob\u00f3 este mi\u00e9rcoles el primer tratamiento semestral preventivo del VIH de venta en el pa\u00eds, seg\u00fan anunci\u00f3 el fabricante del medicamento, Gilead Sciences. El f\u00e1rmaco, llamado Yeztugo (lenacapavir), fue dise\u00f1ado para reducir el riesgo de contraer VIH por v\u00eda sexual en adultos y adolescentes que [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-19T10:28:11+00:00\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH\",\"datePublished\":\"2025-06-19T10:28:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/\"},\"wordCount\":266,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"articleSection\":[\"Noticias\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/\",\"name\":\"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"datePublished\":\"2025-06-19T10:28:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/","og_locale":"es_ES","og_type":"article","og_title":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH","og_description":"La Administraci\u00f3n de Alimentos y Medicamentos (FDA) de Estados Unidos aprob\u00f3 este mi\u00e9rcoles el primer tratamiento semestral preventivo del VIH de venta en el pa\u00eds, seg\u00fan anunci\u00f3 el fabricante del medicamento, Gilead Sciences. El f\u00e1rmaco, llamado Yeztugo (lenacapavir), fue dise\u00f1ado para reducir el riesgo de contraer VIH por v\u00eda sexual en adultos y adolescentes que [&hellip;]","og_url":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/","og_site_name":"bip4ex","article_published_time":"2025-06-19T10:28:11+00:00","author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH","datePublished":"2025-06-19T10:28:11+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/"},"wordCount":266,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"articleSection":["Noticias"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/","url":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/","name":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"datePublished":"2025-06-19T10:28:11+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/ee-uu-aprueba-la-primera-inyeccion-semestral-preventiva-para-el-vih\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"EE UU aprueba la primera inyecci\u00f3n semestral preventiva para el VIH"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/136510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=136510"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/136510\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=136510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=136510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=136510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}